Results 101 to 110 of about 38,863 (158)
, 2010 Margaret M Marczewski1, Marek Postula1,2, Dariusz Kosior111st Chair and Department of Cardiology, Central University Hospital, Medical University of Warsaw, Warsaw, Poland; 2Department of Experimental and Clinical Pharmacology, Medical University of ...
Margaret M Marczewski +2 more
core
Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
, 2018 Juliana Maria Dantas Mendonça Borges,1,2,* Fernanda Oliveira de Carvalho,1,* Isla Alcântara Gomes,3,* Mario Borges Rosa,4,* Antonio Carlos Sobral Sousa1,* 1Nucleus of Post-Graduation in Health Sciences, Federal University of Sergipe, S ...
Borges JMDM +4 more
core
Antiplatelet Agents: A Review [PDF]
Journal of the Royal Society of Medicine, 1979 openaire +2 more sources
Emergence of institutional antithrombotic protocols for coronavirus 2019
Research and Practice in Thrombosis and Haemostasis, 2020 Kevin P. Cohoon +3 more
doaj +1 more source
Antiplatelet Therapy in Elderly.
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 1998 openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Clinical Investigation, 1994
Abstract.The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists.
G A, Fitzgerald, E A, Meagher
openaire +2 more sources
Abstract.The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists.
G A, Fitzgerald, E A, Meagher
openaire +2 more sources
Hematology, 2009
Abstract The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeutic approach in cardiovascular medicine. Since platelets play a key role in the development of arterial thrombosis, antiplatelet drugs serve as a cornerstone in the prevention and the treatment of these conditions.
David, Varon, Galia, Spectre
openaire +2 more sources
Abstract The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeutic approach in cardiovascular medicine. Since platelets play a key role in the development of arterial thrombosis, antiplatelet drugs serve as a cornerstone in the prevention and the treatment of these conditions.
David, Varon, Galia, Spectre
openaire +2 more sources
Medical Journal of Australia, 1999
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is ...
R I, Baker, G J, Hankey
openaire +3 more sources
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is ...
R I, Baker, G J, Hankey
openaire +3 more sources
Antiplatelet resistance in stroke [PDF]
Expert Review of Neurotherapeutics, 2011 Although the exact prevalence of antiplatelet resistance in ischemic stroke is not known, estimates about the two most widely used antiplatelet agents - aspirin and clopidogrel - suggest that the resistance rate is high, irrespective of the definition used and parameters measured. Inadequate antiplatelet responsiveness correlates with an increased risk
Ethem Murat Arsava +2 more
exaly +4 more sources
Reactions Weekly
Highlights: Introduction Goals of Treatment Antiplatelet Therapy Combination Therapy Monographs ...
Megan Willson, Kimberly C. McKeirnan
+4 more sources
Highlights: Introduction Goals of Treatment Antiplatelet Therapy Combination Therapy Monographs ...
Megan Willson, Kimberly C. McKeirnan
+4 more sources